$6.52 0.5%
BVS Stock Price vs. AI Score (Last 150 days)
Data gathered: July 15

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Bioventus

Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body’s natural healing process in the United States and internationally.


Bioventus
Price $6.52
Target Price Sign up
Volume 53,200
Market Cap $418M
Year Range $3.52 - $6.93
Dividend Yield 0%
Revenue per Employee $446,200
Industry Medical Devices

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '24129M121M88M-4.6M-1.7M0.070
Q4 '23135M130M86M-6.1M-4.5M0.070
Q3 '23118M114M79M-7.3M-4.2M0.050
Q2 '23136M126M89M-3.7M-780,0000.140
Q1 '23118M207M74M-139M-137M-0.260

Insider Transactions View All

CHURCH KATRINA J filed to sell 41,199 shares at $5.6.
June 25 '24
D'Adamio Anthony filed to sell 95,576 shares at $5.6.
June 25 '24
Singleton Mark Leonard filed to sell 84,895 shares at $5.6.
June 25 '24
CHURCH KATRINA J filed to sell 35,158 shares at $5.8.
June 21 '24
D'Adamio Anthony filed to sell 81,630 shares at $5.8.
June 21 '24

What is the Market Cap of Bioventus?

The Market Cap of Bioventus is $418M.

How Many People Work at Bioventus?

As of our latest update, Bioventus employed approximately 1,160 people worldwide. However, it's important to note that Bioventus' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Bioventus' revenue per employee?

$446,200. To calculate Bioventus' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Bioventus?

Currently, the price of one share of Bioventus stock is $6.52.

How can I analyze the BVS stock price chart for investment decisions?

The BVS stock price chart above provides a comprehensive visual representation of Bioventus' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Bioventus shares. Our platform offers an up-to-date BVS stock price chart, along with technical data analysis and alternative data insights.

Does BVS offer dividends to its shareholders?

As of our latest update, Bioventus (BVS) does not offer dividends to its shareholders. Investors interested in Bioventus should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Bioventus?

Some of the similar stocks of Bioventus are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.